Back
HFA Premium Access

Anti-thymocyte globulin induction therapy usage is not associated with short and long-term survival differences in heart transplant patients

Session: Poster Session 2 - Cardiovascular Surgery - Transplantation
Topic: Transplantation
Speaker: Mr S. Jia (London, CA)
Event: Heart Failure 2019

Congress Presentation

About the speaker

Mr Sangyang Jia

London Health Sciences Centre, London (Canada)
0 follower

4 more presentations in this session

Long-term survival after heart transplantation or implantation of mechanical circulatory support in patients with advanced heart failure due to giant cell myocarditis or cardiac sarcoidosis

Speaker: Doctor E. Bobbio (Goteborg, SE)

Access
Abstract
Thumbnail

Does the age of the recipient influence the survival of the heart transplant?

Speaker: Doctor R. Lopez Vilella (Valencia, ES)

Access
Abstract
Thumbnail

Usefulness of the biomarker CA125 in the diagnosis of acute cellular rejection in allogeneic heart transplantation

Speaker: Doctor R. Lopez Vilella (Valencia, ES)

Access
Abstract
Thumbnail

The impact of ischemic time and procurement distance on long-term survival following heart transplantation in a tertiary care center: 30 years of experience

Speaker: Mr S. Jia (London, CA)

Access
Abstract
Thumbnail

Access the full session

Poster Session 2 - Cardiovascular Surgery - Transplantation

Speakers: Mr S. Jia, Doctor E. Bobbio, Doctor R. Lopez Vilella, Doctor R. Lopez Vilella, Mr S. Jia
Access
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb